Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
At Hackensack Meridian Well being College Medical Heart’s John Theurer Most cancers Heart (JTCC), the Grownup Stem Cell transplant and Mobile Remedy...
Andrew Dunning's message to sufferers with newly recognized head and neck most cancers emphasizes braveness, neighborhood engagement, and embracing the excellent help...
